Home > Healthcare > Pharmaceuticals > Vaccines > Ebola Virus Vaccine Market

Ebola Virus Vaccine Market Share

Report ID: GMI6083
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Ebola Virus Vaccine Market Share

Major market players operating in the Ebola virus vaccine industry include

Merck & Co., Inc
Johnson & Johnson
Bavarian Nordic
GlaxoSmithKline plc

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition. Also, kindly note that the company profile section include both companies that have commercial drug available in market as well as those that are into clinical phase development.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ebola virus vaccine market accounted for USD 4.4 million in 2022 and is estimated to grow at 32.6% CAGR through 2032, driven by the growing incidence of zoonotic diseases across the globe.

Hospitals segment accounted for USD 1.6 million market revenue in 2022, owing to the availability of skilled medical professionals, better accessibility & convenience, and advanced healthcare infrastructure.

U.S. Ebola virus vaccine market accounted for over 52.3% revenue share in 2022 and will grow at a considerable rate through 2032, backed by the growing demand for preventive healthcare, and rising government investments to create awareness regarding vaccination and controlling outbreaks.

Merck & Co., Inc, Johnson & Johnson, Bavarian Nordic, GlaxoSmithKline plc among others.